Gerald Marit
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Improved 18-FDG PET/CT diagnosis of multiple myeloma diffuse disease by radiomics analysis.
Journal: Nuclear medicine communications
Published: May 18, 2021
Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial.
Journal: JMIR research protocols
Published: January 16, 2020
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.
Journal: Leukemia
Published: October 05, 2018
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.
Journal: Blood
Published: July 14, 2018
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 26, 2017
Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 08, 2017
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 11, 2015
Last Updated: 09/26/2026